UK markets close in 8 hours 13 minutes

SENS Jan 2024 3.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 09:35AM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.0000
Strike3.00
Expiry date2024-01-19
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume87
Open interestN/A
  • Business Wire

    Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

    GERMANTOWN, Md., September 26, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the completion of the ENHANCE Pivotal Clinical Study adult cohort following the recently completed 365-day visit for the final study patient.

  • Business Wire

    Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

    GERMANTOWN, Md., September 14, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

  • Business Wire

    Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

    GERMANTOWN, Md., September 11, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The company also announced it drew down $25 million upon the transaction closing.